Vera Therapeutics Inc Class A (VERA)

SG&A Expenses

$153.89M

TTM · Period ending: · USD

VERA logo

VERA SG&A Expenses

Latest reported$153.89M
VERA TTM SG&A Expenses ($4.04M → $153.89M)
High-resolution chart · PNG

VERA sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Vera Therapeutics Inc Class A SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
153,886,000
123,422,000
100,217,000
80,888,000
62,916,000
49,002,000
40,481,000
30,625,000
26,794,000
24,501,000
23,256,000
24,450,000
24,382,000
23,588,000
21,910,000
18,837,000
16,937,000
14,606,000
11,918,000
9,222,000
6,186,000
4,791,000
4,039,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.